Big data and the internet of things (IoT) are playing a major role in the development and global distribution of modern vaccines.
The rapid development of the COVID-19 vaccines is having a profound effect on the world.
The Covid-19 pandemic revealed the urgent need for the acceleration of vaccine development worldwide.
The Internet of Things (IoT) is a set of gadgets, devices, wearables and machines that can connect to each other and communicate data with each other and that have been powered by consumer products. It is generated by machines, but its value increases according to the data they collect.
On the other hand, Big Data is generated by humans. In a context where not only humans interact with technology to create data, but also machines interact with each other, it is thanks to the human-created Big Data that the elements of the IoT are able to act intelligently and become more sophisticated.
Pharmaceutical companies are harnessing the power of big data and the internet of things to monitor vaccines. The Pfizer and Moderna COVID-19 vaccines rely on stringent temperature controls during transportation and storage.
The distributors are placing heat, humidity, motion and location sensors on the pallets (or even vaccines themselves) to help researchers monitor the vials of vaccine in real time wherever they are in the world and identify weak links in the supply chain.
Vaccination has proven to be an effective measure to control infectious diseases, and the rapid emergence of COVID-19 has shown the importance of developing safe and effective vaccines in a minimal time frame.
Big data and the internet of things can help pharmaceutical companies anticipate the shortage of production and distribution of the newly developed RNA vaccines.